Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR phase II study of lesigercept in adults with chronic spontaneous urticaria inadequately controlled by H1 antihistamines
CTR20261315Phase 2Active
- Sponsor
- Yuhan
- Start
- Jun 2026
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of YH35324 in chronic idiopathic urticaria (CIU), sponsored by Yuhan. Started Jun 2026; status: active.
02
Drugs
YH35324
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on CTR20261315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261315.